Development and validation of a stability indicating HPLC method for the simultaneous analysis of lopinavir and ritonavir in fixed-dose combination tablets-Reference-Cited by-同舟云学术

Development and validation of a stability indicating HPLC method for the simultaneous analysis of lopinavir and ritonavir in fixed-dose combination tablets

Published:2015-09 Issue:3 Volume:10 Page:271-277
ISSN:1658-3612
Container-title:Journal of Taibah University Medical Sciences
language:en
Short-container-title:Journal of Taibah University Medical Sciences

Author:

Hiremath Shivanand N.,Bhirud Charushila H.

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. www.drugbank.ca/drugs/DB01601.

2. The Merck Index;Budavari,1996

3. Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment;Barragan;Expert Opin Pharmacother,2008

4. Lopinavir/ritonavir: a review of its use in the management of HIV infection;Cvetkovic;Drugs,2003

5. Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection;Kaplan;Expert Opin Pharmacother,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of computational approaches in the prediction of spectrogram and chromatogram behaviours of analytes in pharmaceutical analysis: assessment review;Future Journal of Pharmaceutical Sciences;2023-10-12

2. Dose-response and type-dependent effects of antiviral drugs in anaerobic digestion of waste-activated sludge for biogas production;Environmental Science and Pollution Research;2023-05-20

3. Overview of Forced Degradation Analysis for FDA Approved Antiretroviral agents: A Review;Journal of Young Pharmacists;2022-08-17

4. Analytical Methods for the Determination of Major Drugs Used for the Treatment of COVID-19. A Review;Critical Reviews in Analytical Chemistry;2022-02-23

5. Analytical Techniques for the Analysis of Lopinavir and Ritonavir in Pharmaceutical Dosage Form and Biological Matrices: A Review;Current Pharmaceutical Analysis;2021-12-17